These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 24548979)
1. Tetrandrine enhances the anticancer effects of arsenic trioxide in vitro. Chen Y; Li P; Yang S; Tong N; Zhang J; Zhao X Int J Clin Pharmacol Ther; 2014 May; 52(5):416-24. PubMed ID: 24548979 [TBL] [Abstract][Full Text] [Related]
2. Resveratrol and arsenic trioxide act synergistically to kill tumor cells in vitro and in vivo. Zhao XY; Yang S; Chen YR; Li PC; Dou MM; Zhang J PLoS One; 2014; 9(6):e98925. PubMed ID: 24901647 [TBL] [Abstract][Full Text] [Related]
3. Arsenic Trioxide and Artemisinin Act Synergistically to Kill Tumor Cells Zhao X; Yang S; Zhang D; Li Z; Huang C Anticancer Agents Med Chem; 2018; 18(15):2178-2186. PubMed ID: 30179145 [TBL] [Abstract][Full Text] [Related]
4. Synergic effect of 3'-azido-3'-deoxythymidine and arsenic trioxide in suppressing hepatoma cells. Chen C; Zhang Y; Wang Y; Huang D; Xi Y; Qi Y Anticancer Drugs; 2011 Jun; 22(5):435-43. PubMed ID: 21502917 [TBL] [Abstract][Full Text] [Related]
5. Arsenic trioxide induces cervical cancer apoptosis, but specifically targets human papillomavirus-infected cell populations. Wen X; Li D; Zhang Y; Liu S; Ghali L; Iles RK Anticancer Drugs; 2012 Mar; 23(3):280-7. PubMed ID: 22245994 [TBL] [Abstract][Full Text] [Related]
6. Effect of arsenic trioxide on multidrug resistant hepatocellular carcinoma cells. Chan JY; Siu KP; Fung KP Cancer Lett; 2006 May; 236(2):250-8. PubMed ID: 15982806 [TBL] [Abstract][Full Text] [Related]
7. Resveratrol synergistically triggers apoptotic cell death with arsenic trioxide via oxidative stress in human lung adenocarcinoma A549 cells. Gu S; Chen C; Jiang X; Zhang Z Biol Trace Elem Res; 2015 Feb; 163(1-2):112-23. PubMed ID: 25431299 [TBL] [Abstract][Full Text] [Related]
8. Arsenic trioxide exerts synergistic effects with cisplatin on non-small cell lung cancer cells via apoptosis induction. Li H; Zhu X; Zhang Y; Xiang J; Chen H J Exp Clin Cancer Res; 2009 Aug; 28(1):110. PubMed ID: 19664237 [TBL] [Abstract][Full Text] [Related]
9. Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis. Park WH; Seol JG; Kim ES; Hyun JM; Jung CW; Lee CC; Kim BK; Lee YY Cancer Res; 2000 Jun; 60(11):3065-71. PubMed ID: 10850458 [TBL] [Abstract][Full Text] [Related]
10. Effect of As2O3 on cell cycle progression and cyclins D1 and B1 expression in two glioblastoma cell lines differing in p53 status. Zhao S; Tsuchida T; Kawakami K; Shi C; Kawamoto K Int J Oncol; 2002 Jul; 21(1):49-55. PubMed ID: 12063549 [TBL] [Abstract][Full Text] [Related]
11. Arsenic trioxide-induced apoptosis of Hep-2 cell line through modulating intracellular glutathione (GSH) level. Cheng B; Yang X; An L; Gao B; Liu X Auris Nasus Larynx; 2010 Feb; 37(1):89-94. PubMed ID: 19574005 [TBL] [Abstract][Full Text] [Related]
12. Inhibition on LS-174T cell growth and activity of telomerase in vitro and in vivo by arsenic trioxide. Wang X; Wang G; Dong D; Fu S; Yang B Exp Toxicol Pathol; 2008 Sep; 60(6):481-8. PubMed ID: 18606528 [TBL] [Abstract][Full Text] [Related]
13. [Toxicity of arsenic trioxide to human lung adenocarcinoma cell line SPCA1 and its mechanism]. Wei L; Wang XW; Zuo WS Ai Zheng; 2004 Dec; 23(12):1633-8. PubMed ID: 15601551 [TBL] [Abstract][Full Text] [Related]
14. Significance of intracellular arsenic trioxide for therapeutic response in acute promyelocytic leukemia. Sahu GR; Jena RK Am J Hematol; 2005 Feb; 78(2):113-6. PubMed ID: 15682419 [TBL] [Abstract][Full Text] [Related]
15. Radiosensitizing effects of arsenic trioxide on MCF-7 human breast cancer cells exposed to 89 strontium chloride. Liu H; Tao X; Ma F; Qiu J; Wu C; Wang M Oncol Rep; 2012 Nov; 28(5):1894-902. PubMed ID: 22922982 [TBL] [Abstract][Full Text] [Related]
16. [The expression of AQP9 in HepG2 cells affects cell biological behaviors and sensitivity to As2O3]. Tang J; Wang C; Jiang Z Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jun; 31(6):769-74. PubMed ID: 26062419 [TBL] [Abstract][Full Text] [Related]
17. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer. Maeda H; Hori S; Nishitoh H; Ichijo H; Ogawa O; Kakehi Y; Kakizuka A Cancer Res; 2001 Jul; 61(14):5432-40. PubMed ID: 11454688 [TBL] [Abstract][Full Text] [Related]
18. Enhancement of arsenic trioxide-mediated apoptosis using docosahexaenoic acid in arsenic trioxide-resistant solid tumor cells. Baumgartner M; Sturlan S; Roth E; Wessner B; Bachleitner-Hofmann T Int J Cancer; 2004 Nov; 112(4):707-12. PubMed ID: 15382055 [TBL] [Abstract][Full Text] [Related]
19. Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by L-buthionine sulfoximine. Wu XX; Ogawa O; Kakehi Y Int J Oncol; 2004 Jun; 24(6):1489-97. PubMed ID: 15138592 [TBL] [Abstract][Full Text] [Related]
20. [Apoptosis and cell cycle arrest in lymphoma Raji cells induced by arsenic trioxide]. Long Y; Li HM; Qing C; Yu MJ; Zhang YL Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1320-4. PubMed ID: 19099636 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]